Pfizer and Moderna Look to Put COVID Bust Behind Them, Add New Drug Development to Pipelines
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2023/10/guido-hofmann-T9uV8RgsMYA-unsplash-1024x682.jpg)
Several drugmakers whose sales boomed on COVID-19 vaccines and related products in 2021 and 2022 have now been embroiled in a hangover…
McAlinden Research PartnersOctober 18, 2023